Search results

Found 5,205 pages
AUTHOR: Kevin Grogan

Your search yielded no results

  • Check if your spelling is correct.
  • Remove quotes around phrases to search for each word individually. bike shed will often show more results than "bike shed".
  • Consider loosening your query with OR. bike OR shed will often show more results than bike shed.

Sanofi and BI ink biologics manufacturing deal

Sanofi has signed up Boehringer Ingelheim as its partner to manufacture monoclonal antibodies. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/sanofi_and_bi_ink_biologics_manufacturing_deal_970872

B-MS inks fibrosis pact with Calibr

Bristol-Myers Squibb has linked up with the California Institute for Biomedical Research to develop anti-fibrotic therapies. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/b-ms_inks_fibrosis_pact_with_calibr_970805

Roche signs Parkinson's pact with 23andMe

Roche’s Genentech unit has linked up with personal genetics company 23andMe to identify new therapeutic targets for Parkinson’s disease. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/roche_signs_parkinsons_pact_with_23andme_970837

Nestle pact with stem cell biotech CDI

Food giant Nestle has linked up with USA-based stem cell specialist Cellular Dynamics International. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/nestle_pact_with_stem_cell_biotech_cdi_1001327

XTL buys Teva's stake in Proteologics

XTL Biopharmaceuticals has bought a major stake in fellow Israeli drugmaker Proteologics from Teva Pharmaceutical Industries. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/xtl_buys_tevas_stake_in_proteologics_976154

Shire extends offer for ViroPharma again

Shire has extended its tender offer to buy ViroPharma for a second time, now expiring on midnight January 23. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/shire_extends_offer_for_viropharma_again_1001342

Roche buys German genomics group Signature

Roche has hit the acquisition trail again to buy privately-held Signature Diagnostics of Germany. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/roche_buys_german_genomics_group_signature_971024

Amgen biosimilar matches Humira in RA trial

Amgen’s biosimilar of Humira has shown comparable efficacy for moderate-to-severe rheumatoid arthritis in a late-stage trial with AbbVie’s branded inflammatory blockbuster - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/amgen_biosimilar_matches_humira_in_ra_trial_970984

Recordati acquires Tunisia's Opalia

Recordati is buying a 90% stake in Opalia Pharma of Tunisia in a deal valued at 80 million dinar, or around 37 million euros. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/recordati_acquires_tunisias_opalia_1005440

FDA panel mixed on Dynavax hepatitis vaccine

Advisors to the US Food and Drug Administration have backed the efficacy of Dynavax' hepatitis B vaccine Heplisav but expressed concerns about its safety profile. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/fda_panel_mixed_on_dynavax_hepatitis_vaccine_976217

Latest jobs

View all

What job are you looking for?

This field is required.

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download